Repligen Corporation (RGEN) Cash Flow Statement

The OCF-to-NI ratio is essentially uninformative in quarters like 2024Q3 (-75.41x) and 2026Q3 (-1.12x) because net income hovers near zero while operating cash flow runs at $40-49M per quarter, which suggests reported earnings, not cash generation, are the weaker variable in the model. That divergence appears dominated by $228.5M of D&A and $97.1M of stock compensation over the window rather than by favorable accrual movements, since working capital was on balance a modest net user of cash. Investors should treat the conversion quality as structurally high on a cash basis but note that the same non-cash charges inflating operating cash flow also reflect acquisition amortization and dilutive compensation that pressure per-share economics.

Cumulative FCF of roughly $290M over ten quarters against a cumulative net loss indicates the business converts capital efficiently even in its worst earnings period, which supports the view that the destocking trough hit accounting profits harder than cash generation. The trajectory from 6.3% (2025Q1) to double-digit FCF margins across the last four quarters suggests improving end-market demand consistent with the reported revenue recovery, though the step-down from 22.6% to 12.0-18.2% warrants scrutiny on whether working capital drags or mix are tempering the pace. Compared with peers showing FCF margins in the -3% to 15% range, Repligen's cash economics appear notably stronger than its 6.6% net margin alone would imply.

CapEx of approximately $62M over ten quarters against $228.5M of D&A suggests the company is running a structurally light reinvestment model, which may be viable for consumables-driven manufacturing but could also indicate underinvestment in capacity ahead of the reported revenue acceleration. The elevated D&A is itself largely a byproduct of the $125M acquisition program, meaning a meaningful share of depreciation reflects purchased intangibles rather than wearing physical plants, so the maintenance-versus-growth capex split cannot be cleanly separated from these figures. The low capex intensity is a key reason FCF margins exceed net margins by a wide margin, and investors should monitor whether capex/revenue ratio drifts above the historical 2-6% band as capacity is added.

The pattern of large first-quarter working capital outflows (2025Q1 -$26.4M, 2026Q1 -$21.9M) followed by partial reversals suggests seasonal inventory and receivable build dynamics tied to shipment timing rather than a persistent deterioration in collections, though this should be confirmed against disclosed inventory balances. The 2024Q4 source of $33.6M likely reflects destocking-related inventory liquidation, meaning part of that quarter's $39.2M operating cash flow was a one-time release rather than repeatable earnings power. Net working capital consumption of roughly $61M across the window partially offsets the headline cash strength and implies reported operating cash flow overstates the underlying run rate in quarters following a build.

The absence of dividends alongside intermittent buybacks that ceased entirely after 2025Q4 indicates capital returns are discretionary and cyclical, with the $69.7M acquisition in 2025Q1 and $56.1M in 2024Q4 absorbing the bulk of deployable cash in those periods. Given that cumulative FCF of $290M substantially funded both M&A and the modest $22M buyback without visible strain, the deployment profile appears self-funding rather than leverage-dependent, but it leaves little returned to shareholders during a period when reported profitability is compressed. Investors should assess whether the acquisition-led approach is earning its cost, since intangible amortization from these deals is a recurring wedge between operating cash flow and net income.